Multiple Myeloma Research Foundation (MMRF) founder Kathy Giusti attended the Precision Medicine Initiative (PMI) summit several weeks ago, which was hosted by President Barack Obama. In a Forbes guest post, she shared five reasons why we can be optimistic about the initiative, which aims to develop better, targeted therapies that leverages one’s unique genetic makeup.
- Patients are Ready | Patients continue to participate a variety of research programs, such as the Million Veteran Program.
- Its Leadership is the A-Team | The folks behind the PMI are strikingly impressive – just look at their industry experience.
- It’s Powered by Cross-Sector Partnerships | Without partnerships, the PMI wouldn’t be successful. This type of research, on such a big scale, requires collaboration among life sciences, healthcare, academic, and technology companies. Nonprofit and public organizations are also committed to supporting PMI.
- It Has Bipartisan Support | Enough said.
- Obama Has Every Reason to Get It Done | Aside from benefiting humankind, if the president can get this done in his last year, he’ll leave on a high note that people will always remember.
To read the guest post in Forbes, click here.
